Method for detecting biotoxicity of pollutants based on recombinant photobacterium
By using Escherichia coli DH5αpGE-NluxCDABE recombinant luminescent bacteria, the problem of poor tolerance to pH and salinity in the prior art was solved, the sensitivity of pollutants was improved, and efficient biotoxicity detection of heavy metals, organic solvents and organic matters was achieved. Suitable for a wide range of environmental samples.
Patent Information
- Application Number
- CN202310531855.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-11
- Publication Date
- 2024-11-12
AI Technical Summary
Existing genetic recombinant luminescent bacteria have poor tolerance to pH and salinity, narrow adaptability range, and low sensitivity to pollutants, making it difficult to widely use in pollutant biotoxicity detection.
Escherichia coli DH5αpGE-NluxCDABE is used as a recombinant luminescent bacteria. By carrying luxCDABE plasmid, it enhances its tolerance to pH and salinity, and detects the biotoxicity of pollutants through the determination of relative luminescent units and IC50 calculations. It is suitable for heavy metals and organic solvents. and organics and other environmental samples.
It realizes detection with low pH and salinity requirements, improves pollutant sensitivity, expands the application range, and has a simple detection process and high luminous intensity, which is suitable for a wide range of biotoxicity tests.
Smart Images

Figure CN118932010A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of microbial acute toxicity testing, and in particular to a method for detecting the biological toxicity of pollutants based on recombinant luminescent bacteria. Background Art
[0002] According to the different characteristics of toxicity indicators, biological toxicity detection technology can be divided into acute toxicity detection, subchronic toxicity detection, chronic toxicity detection, endocrine disruption detection and genetic toxicity detection. At present, acute toxicity detection technology is widely used, which can indicate the damage caused by short-term contact between environmental pollutants and the body. According to the different test organisms of toxicity test, it can be divided into luminescent bacteria toxicity test, algae toxicity test, flea toxicity test, shellfish toxicity test and fish toxicity test. Among them, the luminescent bacteria method, as a new type of biological toxicity detection technology, overcomes the shortcomings of traditional biological toxicity detection technology such as high test cost, cumbersome test methods and long cycle, and can detect acute toxicity quickly, sensitively, simply and cheaply. It has been widely used in biological comprehensive toxicity tests of various substances such as heavy metals, pesticides, industrial wastewater, antibiotics, soil, etc. In 1995, my country's State Environmental Protection Agency (i.e., the Ministry of Ecology and Environment) announced the national standard for monitoring water quality toxicity by luminescent bacteria method, "Luminescent bacteria method for determination of acute toxicity of water quality (GB / T 15441-1995)". In 2007, China National Petroleum Corporation also issued the enterprise standard "Luminescent Bacteria Method (QSY111-2007)" for monitoring the biological toxicity of oilfield chemicals and drilling fluids by luminescent bacteria. Luminescent bacteria is a commonly used marine luminescent bacteria in my country. During the metabolism process, it can emit blue-green light (fluorescence) with a wavelength of about 490nm. The ATP content in the body is proportional to the luminescence intensity. When toxic substances are added, the active luminescent bacteria will be inhibited or even die, and the ATP content in the body will also decrease or even disappear, and the luminescence will decrease or even reach zero. The luminescent bacteria method has attracted much attention from researchers in various countries in the screening of toxic substances and the biological evaluation of environmental pollution. However, the traditional luminescent bacteria method is easily interfered by the salinity of the sample.
[0003] Chinese patent application CN108226493A discloses a method for detecting the comprehensive toxicity of water bodies such as industrial wastewater by using genetically recombinant luminous bacteria (Escherichia coli HB101 Pucd607) as a detection organism. Although this method overcomes the pH and salt requirements of marine luminous bacteria, it still requires 0.1M KCl to adjust the osmotic pressure, and when the OD550 of the bacterial solution is 0.6-1, the relative luminous unit is greater than 100,000, which has the disadvantage of low luminous intensity and a narrow range of adaptability. Therefore, it is urgent to find a method for detecting the biological toxicity of pollutants with a wider range of use and more sensitive to pollutants. Summary of the invention
[0004] The purpose of the present invention is to overcome the problems that the existing genetically recombinant luminous bacteria have poor tolerance to pH and salinity, a relatively narrow application range, and low sensitivity to pollutants, and to provide a method for detecting the biological toxicity of pollutants based on recombinant luminous bacteria. The method has a wider application range, lower requirements on pH and salinity, and a simpler method; compared with the national standard strain 502 luminous bacteria, the sensitivity is stronger and more in line with the requirements of biological toxicity testing.
[0005] In order to achieve the above object, the present invention provides a method for detecting the biological toxicity of pollutants based on recombinant luminescent bacteria, the method comprising the following steps:
[0006] (1) culturing the recombinant luminescent bacteria to obtain a recombinant luminescent bacteria liquid;
[0007] (2) The pollutant solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the pollutant solutions of different concentrations was calculated, the dose-effect curve was drawn, and the IC was calculated. 50 , the biotoxicity of pollutants is based on IC 50 To judge by the size;
[0008] Wherein, the recombinant luminous bacteria is Escherichia coli DH5αpGE-NluxCDABE, and the pollutants are heavy metal compounds and / or organic matter.
[0009] Preferably, the relative luminescence inhibition rate I is calculated according to formula (1):
[0010] I=RLU / RLU0×100% Formula (1)
[0011] Among them, RLU is the relative luminescence unit corresponding to different pollutant solutions, and RLU0 is the relative luminescence unit corresponding to the blank control group, and the unit is %.
[0012] Preferably, the recombinant luminescent bacteria is obtained by stably transforming Escherichia coli DH5α with a pGENluxCDABE plasmid carrying luxCDABE.
[0013] Preferably, the heavy metal in the heavy metal compound is selected from one or more of gold, silver, copper, iron, mercury, lead, zinc and cadmium.
[0014] Preferably, the heavy metal compound is a heavy metal inorganic salt and / or a heavy metal organic salt.
[0015] More preferably, the heavy metal compound is selected from one or more of heavy metal sulfates, heavy metal nitrates and heavy metal hydrochlorides.
[0016] Particularly preferably, the heavy metal compound is selected from one or more of zinc sulfate, cadmium chloride and copper sulfate.
[0017] Preferably, the organic matter is selected from one or more of aliphatic ketones, aliphatic alcohols, nitriles, alkyl sulfoxides, aliphatic aldehydes and phenols.
[0018] Preferably, the organic matter is selected from one or more of acetone, acetonitrile, ethanol, dimethyl sulfoxide, phenol, o-xylene and formaldehyde.
[0019] Preferably, the step (1) comprises: inoculating the recombinant luminescent bacteria into a culture medium for culturing, then performing subculture, centrifuging, and resuspending to obtain a recombinant luminescent bacteria solution.
[0020] Preferably, the culture medium contains ampicillin, and the concentration of the ampicillin is 45-60 mg / L.
[0021] Preferably, the culture conditions include: temperature of 20-45°C, time of 14-20 hours, and rotation speed of 100-150 rpm.
[0022] Preferably, the conditions for the subculture include: a temperature of 20 to 45° C., a time of 20 to 60 hours, and a rotation speed of 100 to 150 rpm.
[0023] Preferably, the culture is continued until the OD of the bacterial solution is 600 When the value is 0.2-0.4, centrifuge.
[0024] Preferably, when the OD of the bacterial solution is 600 When the value is 0.2 to 0.4, the relative luminous unit is 0.8×10 7 ~1.2×10 7 .
[0025] Preferably, the centrifugal conditions include: temperature of 1-8°C, time of 3-7 min, and rotation speed of 3000-8000 rpm.
[0026] Preferably, water or NaCl solution is used for resuspension.
[0027] Preferably, the concentration of the NaCl solution is 0.3-0.8 wt %.
[0028] Preferably, the step (2) further comprises: before mixing pollutant solutions of different concentrations with the recombinant luminescent bacteria solution, conducting a preliminary experiment to determine the concentration range of the pollutants.
[0029] Preferably, the preliminary experiment includes: diluting the pollutant in a gradient manner, with a gradient difference of 10 times, determining 5 to 8 concentrations of the pollutant solution, and then mixing the pollutant solutions of different concentrations and the blank control group with the recombinant luminescent bacteria solution, respectively, and measuring the relative luminescence units, and calculating the relative luminescence inhibition rate I corresponding to the pollutant solutions of different concentrations, and determining IC 50 The pollutant concentration range is taken as the pollutant concentration range.
[0030] Preferably, in the preliminary experiment, a NaCl solution with a concentration of 0.3 to 0.8 weight % is used as a blank control group.
[0031] Preferably, in the preliminary experiment, a NaCl solution with a concentration of 0.3-0.8 wt % is used to gradiently dilute the pollutants.
[0032] Preferably, the mixing time is 12 to 20 minutes.
[0033] Preferably, in step (2), the blank control group is a NaCl solution with a concentration of 0.3 to 0.8 weight %.
[0034] Preferably, step (2) comprises: after the preliminary experiment, adding 98 to 100 μL of pollutant solutions of different concentrations and a blank control group and 1 μL of recombinant luminescent bacteria solution to a microplate, shaking, and measuring the relative luminescence units after mixing, and calculating the relative luminescence inhibition rate I corresponding to the pollutant solutions of different concentrations.
[0035] Preferably, pollutant solutions of different concentrations are prepared using NaCl solutions with a concentration of 0.3-0.8 wt%.
[0036] Preferably, the mixing time is 12 to 20 minutes.
[0037] Preferably, the abscissa of the dose-effect curve is the concentration C of pollutant solution samples of different concentrations; and the ordinate is the relative luminescence inhibition rate I.
[0038] The present invention adopts specific recombinant luminous bacteria to carry out biological toxicity test, which can be applicable to environmental samples such as heavy metals, organic solvents and organic matter. Compared with the national standard strain 502 luminous bacteria, the recombinant luminous bacteria is more sensitive to environmental samples such as heavy metals, organic solvents and organic matter, and better meets the requirements of biological toxicity test.
[0039] Under preferred conditions, the recombinant luminescent bacteria has a very wide tolerance range for pH values, and there is no need to adjust the pH value of the culture medium during cultivation, and the cultivation steps are relatively simple; and during the test process, the salinity requirement is low, and there is no need to add salt to adjust the osmotic pressure when mixing the pollutant solution with the bacterial solution, and the steps are also relatively simple; and in the present invention, when the OD of the bacterial solution is 0.2-0.4, the relative luminescence unit (luminescence intensity) is 0.8×107 -1.2×10 7 The luminous intensity is higher than that of existing luminous bacteria; during testing, the present invention only needs to add a pollutant sample with a volume of about 99 microliters to test the relative luminous unit, which is less than the existing method.
[0040] In summary, the recombinant luminescent bacteria in the present invention have a very wide tolerance range for pH. The culture medium does not need to be adjusted to 7. 0.5% NaCl can be used to prepare sample solutions of different concentrations, which can reduce the interference of salinity on sample toxicity. There is no need to adjust the osmotic pressure. Compared with the prior art, the culture steps are relatively simple. The luminescence intensity of the recombinant luminescent bacteria is higher than that of the recombinant luminescent bacteria in the prior art. When the OD of the bacterial solution is 0.2-0.4, the relative luminescence unit is as high as 0.8×10 7 ~1.2×10 7 The acute toxicity test method for environmental samples such as heavy metals, organic solvents and organic matter of the present invention has a different application scope from that of the prior art and is more universal. In addition, the present invention uses the national standard strain 502 luminescent bacteria to simultaneously implement toxicity tests on environmental samples, and through comparison of the results, it is found that the recombinant luminescent bacteria is more in line with the requirements of biological toxicity tests than the 502 luminescent bacteria, and is more persuasive than the prior art.
[0041] The present invention is based on genetic engineering technology, and uses a plasmid containing the luminescent gene luxCDABE to construct a recombinant luminescent engineering bacteria, and its reaction principle is similar to that of luminescent bacteria. The recombinant engineering bacteria has the advantages of being stable and reliable in the detection of toxic pollutants, and is very stable during storage or transportation. The feasibility of genetically recombinant luminescent bacteria in biological toxicity testing can be determined through the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 This is a graph of the sodium salt tolerance of different luminescent bacteria;
[0043] Figure 2 is a graph showing the pH tolerance of the recombinant Escherichia coli obtained in Test Example 1;
[0044] Figure 3 is the dose-effect curve corresponding to Example 1 and Comparative Example 1;
[0045] Figure 4 is the dose-effect curve corresponding to Example 2 and Comparative Example 2;
[0046] Figure 5 is the dose-effect curve corresponding to Example 3 and Comparative Example 3;
[0047] Figure 6 is the dose-effect curve corresponding to Example 4 and Comparative Example 4;
[0048] Figure 7is the dose-effect curve corresponding to Example 5 and Comparative Example 5;
[0049] Figure 8 is the dose-effect curve corresponding to Example 6 and Comparative Example 6;
[0050] Fig. 9 is the dose-effect curve corresponding to Example 7 and Comparative Example 7;
[0051] Fig.10 is the dose-effect curve corresponding to Example 8 and Comparative Example 8;
[0052] Fig.11 is the dose-effect curve corresponding to Example 9 and Comparative Example 9;
[0053] Fig.12 It is the dose-effect curve corresponding to Example 10 and Comparative Example 10. DETAILED DESCRIPTION
[0054] The specific implementation of the present invention is described in detail below in conjunction with the accompanying drawings. It should be understood that the specific implementation described here is only used to illustrate and explain the present invention, and is not used to limit the present invention.
[0055] The endpoints and any values of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
[0056] The present invention provides a method for detecting the biological toxicity of pollutants based on recombinant luminescent bacteria, the method comprising the following steps:
[0057] (1) culturing the recombinant luminescent bacteria to obtain a recombinant luminescent bacteria liquid;
[0058] (2) The pollutant solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the pollutant solutions of different concentrations was calculated, the dose-effect curve was drawn, and the IC was calculated. 50 , the biotoxicity of pollutants is based on IC 50 To judge by the size;
[0059] Wherein, the recombinant luminous bacteria is Escherichia coli DH5αpGE-NluxCDABE, and the pollutants are heavy metal compounds and / or organic matter.
[0060] In the method of the present invention, the relative luminescence inhibition rate I is calculated according to formula (1):
[0061] I = RLU / RLU0×100% formula (1); wherein, in formula (1): RLU is the relative luminescence unit corresponding to different pollutant solutions, RLU0 is the relative luminescence unit corresponding to the blank control group, and the unit is %.
[0062] In the present invention, the relative luminescence unit is measured by a chemiluminescence module of a Thermo multifunctional microplate reader; the relative luminescence unit represents the luminescence intensity, and the larger the value of the relative luminescence unit, the stronger the luminescence intensity.
[0063] According to the present invention, the recombinant luminescent bacteria is obtained by stably transforming Escherichia coli DH5α with a pGENluxCDABE low-copy plasmid carrying luxCDABE.
[0064] In the present invention, pGENluxCDABE was purchased from Addgene, and the recombinant luminescent bacteria was obtained by heat transformation of DH5α competent cells. Specifically, 2 ng of pGENluxCDABE plasmid was added to 100 μL of Escherichia coli DH5α competent cell suspension.
[0065] The recombinant luminescent bacteria and the method of the present invention have a wide range of applications and can be applied to environmental samples such as heavy metals and organic matter.
[0066] In the present invention, the heavy metal compound may be a water-soluble compound well known in the art. In a specific embodiment, the heavy metal in the heavy metal compound is selected from one or more of gold, silver, copper, iron, mercury, lead, zinc and cadmium. In a preferred embodiment, the heavy metal in the heavy metal compound is selected from one or more of zinc, cadmium and copper.
[0067] According to the present invention, specifically, the heavy metal compound is a heavy metal inorganic salt and / or a heavy metal organic salt, preferably a heavy metal inorganic salt.
[0068] In a preferred embodiment, the heavy metal compound is selected from one or more of heavy metal sulfates, heavy metal nitrates and heavy metal hydrochlorides.
[0069] In a more preferred embodiment, the heavy metal compound is selected from one or more of zinc sulfate, cadmium chloride and copper sulfate.
[0070] According to the present invention, the organic matter can be a conventional choice in the art. Specifically, the organic matter is selected from one or more of aliphatic ketones, aliphatic alcohols, nitriles, alkyl sulfoxides, aliphatic aldehydes, benzene series and phenols.
[0071] Under preferred conditions, the organic matter is selected from one or more of acetone, acetonitrile, ethanol, dimethyl sulfoxide, phenol, o-xylene and formaldehyde.
[0072] In a specific embodiment, the step (1) comprises: inoculating the recombinant luminescent bacteria into a culture medium for culturing, then performing subculture, centrifuging, and resuspending to obtain a recombinant luminescent bacteria solution.
[0073] The recombinant luminescent bacteria of the present invention have a very wide tolerance range for pH values, and there is no need to adjust the pH value of the culture medium during cultivation, and the cultivation steps are relatively simple.
[0074] According to the present invention, specifically, the culture medium contains ampicillin, and the concentration of the ampicillin can be 45-60 mg / L.
[0075] Under preferred conditions, the culture medium used for culturing the recombinant luminescent bacteria of the present invention is a culture medium obtained by adding ampicillin to LB culture medium.
[0076] In the method of the present invention, specifically, the recombinant luminescent bacteria can be cultured in a shaking incubator, and when the recombinant luminescent bacteria in the culture bottle are full, 50-100 μL of bacterial solution is measured with a pipette and transferred to a new sterilized culture medium for subculture.
[0077] According to the present invention, the culture medium used in the subculture is the same as the culture medium used in the aforementioned culture. Specifically, the culture medium contains ampicillin, and the concentration of the ampicillin can be 45-60 mg / L. Under preferred conditions, the culture medium used in the subculture is a culture medium obtained by adding ampicillin to LB culture medium.
[0078] In a specific embodiment, the culture conditions include: the temperature can be 20-45°C, such as 20°C, 25°C, 30°C, 35°C, 37°C, 40°C or 45°C; the time can be 14-20h; the rotation speed can be 100-150rmp.
[0079] In a specific embodiment, the conditions for the subculture include: the temperature can be 20-45°C; the time can be 20-60h, for example 20h, 24h, 28h, 30h, 35h, 40h, 45h, 48h, 52h, 55h or 60h; the rotation speed can be 100-150rmp.
[0080] According to the present invention, specifically, during the subculture process, 100 μL of bacterial solution was measured with a pipette on a sterile operating table to a white opaque 96-well microplate, and the OD of the bacterial solution was detected using a Thermo multifunctional microplate reader chemiluminescence module. 600 Specifically, the culture was subcultured to an OD of600 When the value is 0.2-0.4, centrifuge.
[0081] The recombinant luminescent bacterial solution of the present invention has a strong luminescent intensity and is more suitable for biological toxicity testing. 600 When the value is 0.2 to 0.4, the relative luminous unit is 0.8×10 7 ~1.2×10 7 .
[0082] In the present invention, the centrifugation can be performed according to conventional operations in the art. In a specific embodiment, a low-temperature high-speed desktop centrifuge is used for centrifugation. Under preferred conditions, the centrifugation temperature is 1 to 8°C, such as 1°C, 2°C, 4°C, 6°C or 8°C; the centrifugation time can be 3 to 7 minutes, such as 3 minutes, 4 minutes, 5 minutes, 6 minutes or 7 minutes; the centrifugation speed can be 3000 to 8000 rpm, such as 3000 rpm, 4000 rpm, 5000 rpm, 6000 rpm, 7000 rpm or 8000 rpm.
[0083] In a specific embodiment, water or NaCl solution can be used for re-suspension, and the water or NaCl solution must be sterilized before use.
[0084] In order to improve the luminous intensity of the recombinant luminescent bacteria liquid, in a preferred embodiment, a NaCl solution is used for resuspension. Under preferred conditions, the concentration of the NaCl solution used for resuspension can be 0.3-0.8 weight%, for example, 0.3 weight%, 0.4 weight%, 0.5 weight%, 0.6 weight%, 0.7 weight% or 0.8 weight%.
[0085] According to the present invention, under preferred conditions, before mixing pollutant solutions of different concentrations with recombinant luminescent bacteria solution for formal experiments, a preliminary experiment is required to determine the concentration range of the pollutants in the formal experiments.
[0086] In a specific embodiment, the preliminary experiment includes: diluting the pollutant in a gradient manner, with a gradient difference of 10 times, determining 5 to 8 pollutant solution concentrations, and then mixing the pollutant solutions of different concentrations and the blank control group with the recombinant luminescent bacteria solution, respectively, and determining the relative luminescence units, and calculating the relative luminescence inhibition rate I corresponding to the pollutant solutions of different concentrations, and determining IC 50 The pollutant concentration range is used as the pollutant concentration range, so that the luminescence inhibition rate after the pollutant solution and the recombinant luminescent bacteria solution are mixed in the formal experiment is evenly distributed at the concentration points above and below 50%. 50 It refers to the half inhibition concentration of the pollutant being measured.
[0087] Under optimal conditions, 3 to 5 parallel experiments can be performed for each group of experiments in the preliminary experiment.
[0088] In a specific embodiment, a sterile NaCl solution with a concentration of 0.3-0.8 wt%, preferably 0.5 wt%, can be used as a blank control group in the preliminary experiment. Similarly, a sterile NaCl solution with a concentration of 0.3-0.8 wt%, preferably 0.5 wt%, can be used in the preliminary experiment to perform gradient dilution of the pollutant.
[0089] According to the present invention, under preferred conditions, the mixing time can be 12 to 20 minutes, for example, 12 minutes, 14 minutes, 15 minutes, 16 minutes, 18 minutes or 20 minutes.
[0090] In a preferred embodiment, in order to enhance the luminescence intensity of the recombinant luminescent bacteria solution, in step (2), the blank control group in the formal experiment can be a NaCl solution with a concentration of 0.3-0.8 wt%.
[0091] In a specific embodiment, step (2) includes: after the preliminary experiment, 98 to 100 μL of pollutant solutions of different concentrations and a blank control group are added to the microplate with 1 μL of the recombinant luminescent bacteria solution, shaken, and mixed, and then the relative luminescence units are measured, and the relative luminescence inhibition rate I corresponding to the pollutant solutions of different concentrations is calculated. Under preferred conditions, when the present invention is used for formal experiments, 3 to 5 parallel experiments can be performed for each group of experiments.
[0092] According to the present invention, under preferred conditions, pollutant solutions of different concentrations are prepared using a NaCl solution with a concentration of 0.3-0.8 wt%, preferably 0.5 wt%. In a specific embodiment, the mixing time can be 12-20 min, such as 12 min, 14 min, 15 min, 16 min, 18 min or 20 min.
[0093] In the method of the present invention, the abscissa of the dose-effect curve in step (2) is the concentration C of pollutant solutions of different concentrations; and the ordinate is the relative luminescence inhibition rate I.
[0094] According to the present invention, the dose-effect curve of the biological toxicity of the test substance is represented by a nonlinear function, and the Probit regression analysis in SPSS software is adopted and the nonlinear fitting is performed with the Logit function.
[0095] In a preferred embodiment, in step (2), when the pollutant is zinc sulfate, the concentration of the zinc sulfate solution is 0-0.1 mM during the formal experiment; more preferably, the function of the dose-effect curve fitting is: y=-2.2454x 2 -5.0467x+116.39, R2 It is 0.9108.
[0096] In a preferred embodiment, in step (2), when the pollutant is cadmium chloride, the concentration of the cadmium chloride solution is 0-0.25 mM during the formal experiment; more preferably, the function of the dose-effect curve fitting is: y=98.922e-4.508x, R 2 It is 0.9819.
[0097] In a preferred embodiment, in step (2), when the pollutant is copper sulfate, the concentration of the copper sulfate solution is 0-0.011 mM during the formal experiment; more preferably, the function of the dose-effect curve fitting is: y=644968x 2 -14616x+99.241, R 2 It is 0.9938.
[0098] In a preferred embodiment, in step (2), when the pollutant is dimethyl sulfoxide, the concentration of the dimethyl sulfoxide solution is 0 to 3 M during the formal experiment; more preferably, the function of the dose-effect curve fitting is: y = -31.027x + 103.56, R 2 It is 0.974.
[0099] In a preferred embodiment, in step (2), when the pollutant is acetone, the concentration of the acetone solution is 0-7M during the formal experiment; more preferably, the function of the dose-effect curve fitting is: 99.993e-1.1x, R 2 It is 0.8562.
[0100] In a preferred embodiment, in step (2), when the pollutant is acetonitrile, the concentration of the acetonitrile solution is 0-5M during the formal experiment; more preferably, the function of the dose-effect curve fitting is: y=168.26e-1.562x, R 2 It is 0.9051.
[0101] In a preferred embodiment, in step (2), when the pollutant is ethanol, the concentration of the ethanol solution is 0 to 3 M during the formal experiment; more preferably, in step (2), the function of the dose-effect curve fitting is: y = -44.186x + 102.35, R 2 is 0.9915.
[0102] In a preferred embodiment, in step (2), when the pollutant is formaldehyde, the concentration of the formaldehyde solution is 0-0.0014 mM during the formal experiment; more preferably, the function of the dose-effect curve fitting is: y=30000000x 2 -95932x+99.495,R2 It is 0.9909.
[0103] In a preferred embodiment, in step (2), when the pollutant is phenol, the concentration of the phenol solution is 0-50 mM during the formal experiment; more preferably, the function of the dose-effect curve fitting is: y=148.13e-72.29x, R 2 It is 0.9907.
[0104] In a preferred embodiment, in step (2), when the pollutant is o-xylene, the concentration of the o-xylene solution is 0 to 12 M during the formal experiment; more preferably, the function of the dose-effect curve fitting is: y = -0.067x 2 -6.8559x+98.124, R 2 =0.9689.
[0105] The present invention will be described in detail below through examples, but the protection scope of the present invention is not limited thereto.
[0106] In the following examples, the medium Amp-LB used was obtained by adding ampicillin to LB medium, and the concentration of the ampicillin was 50 mg / L, wherein the LB medium was purchased from Shanghai Bioengineering, model A507003-0250; and ampicillin was purchased from Biowind.
[0107] Preparation Example 1
[0108] Preparation Example 1 is used to illustrate the preparation process of the recombinant luminescent bacteria Escherichia coli DH5αpGE-NluxCDABE.
[0109] Take Escherichia coli Escherichiacoli DH5α competent cells (purchased from Biowind) and thaw them in an ice bath to obtain Escherichiacoli DH5α competent cell suspension (if aliquoting is required, the thawed Escherichiacoli DH5α competent cell suspension can be aliquoted into sterile pre-cooled centrifuge tubes and stored in an ice bath); add 2 ng of pGENluxCDABE plasmid (purchased from Addgene) to 100 μL of Escherichiacoli DH5α competent cell suspension, mix well, stand at 4°C for 30 minutes, then place in a 42°C water bath for 80 seconds, and then immediately The mixture was allowed to stand and cool in an ice bath for 2.5 minutes, and then 900 μL of sterile LB medium without antibiotics was added. After mixing, the mixture was placed in a shaker and cultured at 37°C for 45 minutes (150 rpm) to obtain transformed EscherichiacoliDH5α competent cells. 100 μL of the transformed EscherichiacoliDH5α competent cells was added to 50 mL of Amp-LB medium containing 50 mg / L ampicillin, and cultured at 37°C for 15 hours to obtain recombinant Escherichia coli EscherichiacoliDH5αpGEN-luxCDABE (D-plux).
[0110] Test Example 1
[0111] 1. The sodium salt tolerance of Photobacterium luminescens PP502 and the recombinant Escherichia coli D-plux obtained in Preparation Example 1 was detected. The detection method was: preparing solutions with different salt concentrations and detecting the luminescence inhibition of different bacteria under different salt concentrations.
[0112] The recombinant Escherichia coli D-plux was subcultured and cultured for 17 hours. When the bacteria were in the exponential growth phase, 5 mL of the bacterial solution was aspirated and centrifuged at 5000 rpm for 5 min. The supernatant was discarded and the sample was resuspended in pure water. The RLU was adjusted to 200,000 to obtain a bacterial suspension. 99 μL of each salt concentration solution (0%, 0.5%, 0.85%, 1%, 1.5%, 2%, 2.5%, and 3% NaCl solution) was taken and 1 μL of the bacterial suspension with an RLU of 200,000 was added to each of them. The RLU was detected on a white ELISA plate using a light-emitting module.
[0113] The Photobacterium luminescens PP502 was subcultured and cultured for 18 hours. When the bacteria was in the exponential growth phase, 5 mL of the bacterial solution was aspirated and centrifuged at 5000 rpm for 5 min. The supernatant was discarded and resuspended in 3% (w / v%) NaCl solution. The RLU was adjusted to 200000 to obtain a bacterial suspension. 99 μL of each solution with different salt concentrations (0%, 0.5%, 0.85%, 1%, 1.5%, 2%, 2.5%, and 3% NaCl solution) was taken and 1 μL of the bacterial suspension with an RLU of 200000 was added respectively. The RLU was detected on a white ELISA plate using a light-emitting module.
[0114] The results are as follows Figure 1 As shown, according to Figure 1 It can be seen that the Photobacterium luminescens PP502 has a relatively high requirement for salt concentration, basically between 1% and 3%; the recombinant Escherichia coli D-plux has a low requirement for salt concentration and can have good luminescence in the range of 0% to 2%.
[0115] 2. The pH tolerance of the recombinant Escherichia coli D-plux obtained in Preparation Example 1 was tested by the following method:
[0116] HCl, NaOH and water were used to prepare solutions with different pH values (pH = 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13), and the luminescence inhibition of the recombinant bacteria under different pH conditions was detected.
[0117] The recombinant Escherichia coli D-plux was subcultured for 18 hours. When the bacteria were in the exponential growth phase, 5 mL of the bacterial solution was aspirated and centrifuged at 5000 rpm for 5 min. The supernatant was discarded and the solution was resuspended in pure water. The RLU was adjusted to 200,000 to obtain a bacterial suspension. 99 μL of each solution with different pH values was taken and 1 μL of the bacterial suspension with an RLU of 200,000 was added to each of them. The RLU was detected on a white ELISA plate using a light-emitting module.
[0118] The results are as follows Figure 2 As shown, according to Figure 2 It can be seen that the recombinant E. coli D-plux has a very high tolerance range for pH values and can emit bright light almost from 4 to 12.
[0119] Examples 1-3 are used to illustrate the method of detecting the biological toxicity of heavy metal pollutants based on recombinant luminescent bacteria.
[0120] Example 1 is used to illustrate the process of detecting the biological toxicity of ZnSO4 based on recombinant luminescent bacteria.
[0121] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0122] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 30℃ and 110rmp for 14h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0123] (2) Preparation of bacterial solution
[0124] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0125] (3) Preliminary experiment
[0126] ZnSO4 was gradiently diluted with 0.5 wt% sterile NaCl solution, and 0.5 wt% sterile NaCl solution was used as blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The ZnSO4 solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the ZnSO4 solutions of different concentrations was calculated to determine the IC 50 The ZnSO4 concentration range is taken as the final concentration range of the toxicity test.
[0127] (4) Formal Experiment
[0128] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare ZnSO4 solutions with concentrations of 0mM, 0.01mM, 0.015mM, 0.03mM, 0.06mM and 0.09mM, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99μL of ZnSO4 solution and 1μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25℃±2℃ was quickly placed to mix, slightly shaken, and mixed evenly for 15min. The relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to the ZnSO4 solution of different concentrations was calculated.
[0129] (5) Data processing
[0130] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of ZnSO4 solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (such as Figure 3 As shown), we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting, and the obtained functional relationship was: y = -2.2454x 2 -5.0467x+116.39, R 2 It is 0.9108.
[0131] Comparative Example 1
[0132] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of ZnSO4 on 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0133] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for future use. The IC value of the toxicity test of ZnSO4 solution was determined by preliminary experiments. 50 After the concentration range, different concentration gradients of ZnSO4 solution were set within this range, namely 0mM, 0.015mM, 0.03mM, 0.06mM, 0.09mM and 0.12mM, and each gradient was repeated 3 times. All concentrations of solutions were gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99μL of ZnSO4 solution and 1μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2℃ plate shaker for mixing for 15min, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to the different concentrations of ZnSO4 solution was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Figure 3 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = -29.21ln(x) -26.655, R 2 It is 0.9708.
[0134] Example 2
[0135] Example 2 is used to illustrate the process of detecting the biological toxicity of CdCl2 based on recombinant luminescent bacteria.
[0136] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0137] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 31℃ and 112rpm for 15h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0138] (2) Preparation of bacterial solution
[0139] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0140] (3) Preliminary experiment
[0141] CdCl2 was gradiently diluted with 0.5 wt% sterile NaCl solution, and 0.5 wt% sterile NaCl solution was used as blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The CdCl2 solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the CdCl2 solutions of different concentrations was calculated to determine the IC 50 The CdCl2 concentration range is taken as the final concentration range of the toxicity test.
[0142] (4) Formal Experiment
[0143] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare CdCl2 solutions with concentrations of 0mM, 0.01mM, 0.05mM, 0.1mM, 0.15mM, and 0.20mM, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99μL of CdCl2 solution and 1μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25℃±2℃ was quickly placed to mix, slightly shaken, and mixed evenly for 15min. The relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to the CdCl2 solution of different concentrations was calculated.
[0144] (5) Data processing
[0145] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of CdCl2 solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (such as Figure 4 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = 98.922e-4.508x, R 2 It is 0.9819.
[0146] Comparative Example 2
[0147] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of CdCl2 on 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0148] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for future use. The IC value of the toxicity test of CdCl2 solution was determined by preliminary experiments. 50 After the concentration range, different concentration gradients of CdCl2 solution were set within this range, namely 0mM, 0.02mM, 0.04mM, 0.08mM, 0.16mM and 0.32mM, and each gradient was repeated 3 times. All concentrations of solutions were gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99μL of CdCl2 solution and 1μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2℃ plate shaker for mixing for 15min, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to the CdCl2 solution of different concentrations was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Figure 4 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = 112.02e-4.034x, R 2 It is 0.9512.
[0149] Example 3 is used to illustrate the process of detecting the biological toxicity of CuSO4 based on recombinant luminescent bacteria.
[0150] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0151] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 32℃ and 114rmp for 16h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0152] (2) Preparation of bacterial solution
[0153] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0154] (3) Preliminary experiment
[0155] CuSO4 was diluted with 0.5 wt% sterile NaCl solution for gradient dilution, and 0.5 wt% sterile NaCl solution was used as blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The relative luminescence units were measured after the different concentrations of CuSO4 solutions and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence inhibition rate I corresponding to the different concentrations of CuSO4 solutions was calculated to determine IC 50 The CuSO4 concentration range is taken as the final concentration range of the toxicity test.
[0156] (4) Formal Experiment
[0157] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare CuSO4 solutions with concentrations of 0mM, 0.004mM, 0.005mM, 0.006mM, 0.007mM, 0.008mM, 0.009mM and 0.01mM, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99μL of CuSO4 solution and 1μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25℃±2℃ was quickly placed to mix, slightly shaken, and mixed evenly for 15min, and the relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to the CuSO4 solution of different concentrations was calculated.
[0158] (5) Data processing
[0159] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of CuSO4 solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (such as Figure 5 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting, and the obtained functional relationship was: y = 644968x 2 -14616x+99.241, R 2 It is 0.9938.
[0160] Comparative Example 3
[0161] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of CuSO4 on 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality by Luminescent Bacteria (GB / T 15441-1995)". The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for standby use. The IC value of the CuSO4 solution was determined by preliminary experiment. 50After the concentration range, different concentration gradients of CuSO4 solution were set within this range, namely 0mM, 0.075mM, 0.15mM, 0.3mM, 0.45mM, 0.6mM and 0.75mM, and each gradient was repeated 3 times. All concentrations of the solution were gradiently diluted using a sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99 μL of CuSO4 solution and 1 μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2°C plate shaker for mixing for 15 minutes, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to the CuSO4 solution of different concentrations was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Figure 5 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting, and the obtained functional relationship was: y = 172.4x 2 -205.02x+92.738, R 2 It is 0.8861.
[0162] Test Example 2
[0163] Calculation of IC of metal contaminants in Examples 1-3 and Comparative Examples 1-3 50 , the results are shown in Table 1.
[0164] Table 1
[0165] serial number Bacteria heavy metal <![CDATA[IC 50 (mM)]]> Example 1 Recombinant luminescent bacteria Zn 0.031 Comparative Example 1 PP502 Zn 0.072 Example 2 Recombinant luminescent bacteria Cd 0.149 Comparative Example 2 PP502 Cd 0.205 Example 3 Recombinant luminescent bacteria Cu 0.003 Comparative Example 3 PP502 Cu 0.259
[0166] It can be seen from Table 1 that the recombinant luminescent bacteria of the present invention are more sensitive to heavy metals Zn, Cu and Cd than the luminescent bacteria PP502.
[0167] Examples 4-7 are used to illustrate the method of detecting the biological toxicity of organic solvents based on recombinant luminescent bacteria.
[0168] Example 4 is used to illustrate the process of detecting acetone biological toxicity based on recombinant luminescent bacteria.
[0169] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0170] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 34℃ and 116rpm for 17h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0171] (2) Preparation of bacterial solution
[0172] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0173] (3) Preliminary experiment
[0174] Acetone was gradiently diluted with 0.5 wt% sterile NaCl solution, and 0.5 wt% sterile NaCl solution was used as a blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The acetone solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the acetone solutions of different concentrations was calculated to determine the IC 50 The acetone concentration range was taken as the final concentration range of the toxicity test.
[0175] (4) Formal Experiment
[0176] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare acetone solutions with concentrations of 0M, 0.4M, 0.8M, 1.6M, 3.2M and 6.4M, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99 μL of acetone solution and 1 μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25°C ± 2°C was quickly placed to mix, slightly shaken, and mixed evenly for 15 minutes. The relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to acetone solutions of different concentrations was calculated.
[0177] (5) Data processing
[0178] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of acetone solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (such as Figure 6As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = 99.993e-1.1x, R 2 It is 0.8562.
[0179] Comparative Example 4
[0180] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of acetone to 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0181] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for future use. The IC value of the toxicity test of acetone solution was determined by preliminary experiments. 50 After the concentration range, different concentration gradients of acetone solution were set within this range, namely 0M, 0.1M, 0.2M, 0.25M, 0.3M and 0.4M, with 3 parallels for each gradient. All concentrations of solutions were gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99 μL of acetone solution and 1 μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2°C plate shaker for mixing for 15 minutes, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to acetone solutions of different concentrations was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Figure 6 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = -199.25x + 94.641, R 2 It is 0.9618.
[0182] Example 5 is used to illustrate the process of detecting the biological toxicity of acetonitrile based on recombinant luminescent bacteria.
[0183] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0184] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 35℃ and 117rpm for 18h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0185] (2) Preparation of bacterial solution
[0186] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0187] (3) Preliminary experiment
[0188] Acetonitrile was gradiently diluted with 0.5 wt% sterile NaCl solution, and 0.5 wt% sterile NaCl solution was used as blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The acetonitrile solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the acetonitrile solution of the same concentration was calculated to determine the IC 50 The acetonitrile concentration range was used as the final concentration range for the toxicity test.
[0189] (4) Formal Experiment
[0190] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare acetonitrile solutions with concentrations of 0M, 1.2M, 1.7M, 2.4M, 3.3M and 4.6M, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99 μL of acetonitrile solution and 1 μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25°C ± 2°C was quickly placed to mix, slightly shaken, and mixed evenly for 15 minutes. The relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to acetonitrile solutions of different concentrations was calculated.
[0191] (5) Data processing
[0192] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of acetonitrile solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (such as Figure 7As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = 168.26e-1.562x, R 2 It is 0.9051.
[0193] Comparative Example 5
[0194] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of acetonitrile to 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0195] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for future use. The IC value of the toxicity test of acetonitrile solution was determined by preliminary experiments. 50 After the concentration range, different concentration gradients of acetonitrile solution were set within this range, namely 0M, 0.1M, 0.2M, 1M, 1.5M and 2M, with 3 parallels for each gradient. All concentrations of solutions were gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99 μL of acetonitrile solution and 1 μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2°C plate shaker for mixing for 15 minutes, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to acetonitrile solutions of different concentrations was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Figure 7 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = 92.987e-1.982x, R 2 It is 0.9917.
[0196] Example 6 is used to illustrate the process of detecting ethanol biotoxicity based on recombinant luminescent bacteria.
[0197] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0198] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 36℃ and 118rpm for 19h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0199] (2) Preparation of bacterial solution
[0200] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0201] (3) Preliminary experiment
[0202] Ethanol was diluted with 0.5 wt% sterile NaCl solution in a gradient manner, and 0.5 wt% sterile NaCl solution was used as a blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The ethanol solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the ethanol solutions of different concentrations was calculated to determine the IC 50 The ethanol concentration range was taken as the final concentration range of the toxicity test.
[0203] (4) Formal Experiment
[0204] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare ethanol solutions with concentrations of 0M, 1M, 1.5M, 2M, 2.5M and 3M, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99 μL of ethanol solution and 1 μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25°C ± 2°C was quickly placed to mix, slightly shaken, and mixed evenly for 15 minutes. The relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to ethanol solutions of different concentrations was calculated.
[0205] (5) Data processing
[0206] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of the ethanol solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (such as Figure 8 As shown), select Probit regression analysis in SPSS software and use Logit function for nonlinear fitting, and the obtained functional relationship is: y = -9.1416x2 -9.9931x+107.95, R 2 It is 0.8881.
[0207] Comparative Example 6
[0208] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of ethanol to 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0209] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for later use. The IC value of the toxicity test of the ethanol solution was determined by preliminary experiments. 50 After the concentration range, different concentration gradients of ethanol solutions were set within this range, namely 0M, 0.25M, 0.5M, 1M, 1.5M and 2M, with 3 parallels for each gradient. Solutions of all concentrations were gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99 μL of ethanol solution and 1 μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2°C plate shaker for mixing for 15 minutes, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to ethanol solutions of different concentrations was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Figure 8 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = -44.186x + 102.35, R 2 is 0.9915.
[0210] Example 7 is used to illustrate the process of detecting the biological toxicity of dimethyl sulfoxide (DMSO) based on recombinant luminescent bacteria.
[0211] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0212] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 37℃ and 119rpm for 20h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0213] (2) Preparation of bacterial solution
[0214] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0215] (3) Preliminary experiment
[0216] DMSO was gradiently diluted with 0.5 wt% sterile NaCl solution, and 0.5 wt% sterile NaCl solution was used as blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The DMSO solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the DMSO solutions of different concentrations was calculated to determine the IC 50 The DMSO concentration range was used as the final concentration range for the toxicity test.
[0217] (4) Formal Experiment
[0218] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare DMSO solutions with concentrations of 0M, 1M, 1.5M, 2M, 2.3M and 2.6M, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99 μL of DMSO solution and 1 μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25°C ± 2°C was quickly placed to mix, slightly shaken, and mixed evenly for 15 minutes. The relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to different concentrations of DMSO solutions was calculated.
[0219] (5) Data processing
[0220] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of DMSO solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (such as Fig. 9As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = -31.027x + 103.56, R 2 It is 0.974.
[0221] Comparative Example 7
[0222] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of DMSO on 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0223] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for future use. The IC value of the toxicity test of DMSO solution was determined by preliminary experiments. 50 After the concentration range, different concentration gradients of DMSO solution were set within this range, namely 0M, 0.1M, 0.2M, 0.4M, 0.8M, 1.6M and 3.2M, and each gradient was repeated 3 times. All concentrations of solutions were gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99 μL of DMSO solution and 1 μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2°C plate shaker for mixing for 15 minutes, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to the different concentrations of DMSO solution was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Fig. 9 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting, and the obtained functional relationship was: y = 13.474x 2 -70.941x+99.112, R 2 is 0.9976.
[0224] Test Example 3
[0225] Calculation of IC of organic solvent contaminants in Examples 4-7 and Comparative Examples 4-7 50 , the results are shown in Table 2.
[0226] Table 2
[0227] serial number Bacteria Organic solvents <![CDATA[IC 50 (M)]]> Example 4 Recombinant luminescent bacteria acetone 1.057 Comparative Example 4 PP502 acetone 0.16 Example 5 Recombinant luminescent bacteria Acetonitrile 1.385 Comparative Example 5 PP502 Acetonitrile 0.201 Example 6 Recombinant luminescent bacteria Ethanol 1.564 Comparative Example 6 PP502 Ethanol 1.031 Example 7 Recombinant luminescent bacteria DMSO 1.589 Comparative Example 7 PP502 DMSO 0.682
[0228] It can be seen from Table 2 that the recombinant luminescent bacteria of the present invention are more sensitive to the organic solvents acetone, acetonitrile, ethanol and DMSO than the luminescent bacteria PP502.
[0229] Examples 8-9 are used to illustrate the method of detecting the biological toxicity of organic matter based on recombinant luminescent bacteria.
[0230] Example 8 is used to illustrate the process of detecting formaldehyde biological toxicity based on recombinant luminescent bacteria.
[0231] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0232] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 38℃ and 120rpm for 16.5h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0233] (2) Preparation of bacterial solution
[0234] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0235] (3) Preliminary experiment
[0236] Formaldehyde was gradiently diluted with 0.5 wt% sterile NaCl solution, and 0.5 wt% sterile NaCl solution was used as blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The formaldehyde solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the formaldehyde solutions of different concentrations was calculated to determine the IC 50 The formaldehyde concentration range is taken as the final concentration range of the toxicity test.
[0237] (4) Formal Experiment
[0238] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare formaldehyde solutions with concentrations of 0mM, 0.000616mM, 0.00070mM, 0.00080mM, 0.0010mM and 0.00123mM, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99μL of formaldehyde solution and 1μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25℃±2℃ was quickly placed to mix, slightly shaken, and mixed evenly for 15min, and the relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to formaldehyde solutions of different concentrations was calculated.
[0239] (5) Data processing
[0240] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of the formaldehyde solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (e.g. Fig.10 As shown), we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting, and the obtained functional relationship was: y = 30000000x 2 -95932x+99.495,R 2 It is 0.9909.
[0241] Comparative Example 8
[0242] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of formaldehyde on 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0243] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for future use. The IC value of the toxicity test of the formaldehyde solution was determined by preliminary experiments. 50After the concentration range is determined, different concentration gradients of formaldehyde solution are set within this range, namely 0mM, 7.58912mM, 8.67328mM, 10.11883mM, 12.64853mM, and 15.17824mM, respectively. Each gradient has 3 parallels, and all concentrations of solutions are gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99μL of formaldehyde solution and 1μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2℃ plate shaker for mixing for 15min, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to formaldehyde solutions of different concentrations was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Fig.10 As shown), we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting, and the obtained functional relationship was: y = -0.1916x 2 -2.8458x+101.93, R 2 It is 0.9156.
[0244] Example 9 is used to illustrate the process of detecting the biological toxicity of phenol based on recombinant luminescent bacteria.
[0245] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0246] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 40℃ and 122rpm for 17.5h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0247] (2) Preparation of bacterial solution
[0248] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0249] (3) Preliminary experiment
[0250] Phenol was gradiently diluted with 0.5 wt% sterile NaCl solution, and 0.5 wt% sterile NaCl solution was used as blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. The phenol solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the phenol solutions of different concentrations was calculated to determine the IC 50 The phenol concentration range was taken as the final concentration range of the toxicity test.
[0251] (4) Formal Experiment
[0252] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare phenol solutions with concentrations of 0mM, 2.75mM, 5.5mM, 11mM, 22mM and 44mM, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99μL of phenol solution and 1μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25℃±2℃ was quickly placed to mix, slightly shaken, and mixed evenly for 15min. The relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to the phenol solutions of different concentrations was calculated.
[0253] (5) Data processing
[0254] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of the phenol solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was plotted with different concentrations of C as the abscissa and the relative luminescence inhibition rate I as the ordinate (e.g. Fig.11 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = 148.13e-72.29x, R 2 It is 0.9907.
[0255] Comparative Example 9
[0256] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of phenol to 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0257] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for future use. The IC value of the phenol solution for toxicity test was determined by preliminary experiments. 50After the concentration range, different concentration gradients of phenol solution were set within this range, namely 0mM, 0.011mM, 0.01467mM, 0.022mM, 0.044mM and 0.088mM, with 3 parallels for each gradient. Solutions of all concentrations were gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99μL of phenol solution and 1μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2℃ plate shaker for mixing for 15min, and the relative light units were measured using the Thermo multifunctional microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to phenol solutions of different concentrations was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Fig.11 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting. The obtained functional relationship was: y = 96.016e-0.178x, R 2 =0.9573.
[0258] Example 10 is used to illustrate the process of detecting the biological toxicity of o-xylene based on recombinant luminescent bacteria.
[0259] (1) Resuscitation and subculture of recombinant luminescent bacteria
[0260] Take out the frozen stock of recombinant luminescent bacteria from the -20℃ refrigerator. After the bacterial solution thaws, quickly extract 15μL and add it to the medium Amp-LB for recovery. Then place it in a shaking incubator at 41℃ and 124rmp for 18.5h. When the recombinant luminescent bacteria in the culture bottle are full, use a pipette to measure 80μL of the bacterial solution and transfer it to 250mL of new sterilized medium Amp-LB for subculture.
[0261] (2) Preparation of bacterial solution
[0262] After 36 hours of subculture, 100 μL of bacterial solution was measured with a pipette on a sterile operating table and transferred to a white opaque 96-well microplate. The OD of the recombinant luminescent bacteria was detected using the chemiluminescence module of a Thermo multifunctional microplate reader. 600 The value is 0.3, and the relative luminous unit is stable at 1×10 7 When the solution was prepared, 50 mL was taken and centrifuged in a low-temperature high-speed desktop centrifuge at 4°C and 5000 rpm for 5 min, and then resuspended in a 0.5 wt % sterilized NaCl solution to obtain a recombinant luminescent bacteria solution and stored at 4°C for later use.
[0263] (3) Preliminary experiment
[0264] o-xylene was gradiently diluted with 0.5 wt% sterile NaCl solution, and 0.5 wt% sterile NaCl solution was used as blank control. Five exposure concentrations were determined with a gradient difference of 10 times, and 3 parallels were performed in each group. Different concentrations of o-xylene solutions and blank control group were mixed with recombinant luminescent bacteria solution for 15 minutes, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to different concentrations of o-xylene solutions was calculated to determine IC 50 The o-xylene concentration range is taken as the final concentration range of the toxicity test.
[0265] (4) Formal Experiment
[0266] According to the results of the preliminary experiment, 0.5 wt% NaCl solution was used to prepare o-xylene solutions with concentrations of 0M, 2M, 4M, 6M, 8M and 10M, respectively, so that the luminescence inhibition rate was evenly distributed at the concentration points above and below 50%, and three parallel tests were performed for each concentration. A white opaque 96-well microplate was used, and 99 μL of o-xylene solution and 1 μL of recombinant luminescent bacteria solution were added to each well, and the plate shaker at 25°C ± 2°C was quickly placed to mix, slightly shaken, and mixed evenly for 15 minutes. The relative luminescence unit was determined using the Thermo multifunctional microplate reader chemiluminescence module, and the relative luminescence inhibition rate I corresponding to the o-xylene solutions of different concentrations was calculated.
[0267] (5) Data processing
[0268] The relative luminescence inhibition rate I (%) was calculated from the average relative luminescence units of the parallel samples, I = RLU / RLU0 × 100%. RLU: average luminescence intensity of o-xylene solution, RLU0: average luminescence intensity of the blank control group. One-way ANOVA was performed using SPSS statistical analysis software. The dose-effect curve of the biological toxicity of the test substance was drawn with different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis (such as Fig.12 As shown in the figure, we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting, and the obtained functional relationship was: y = -0.067x 2 -6.8559x+98.124,R 2 =0.9689.
[0269] Comparative Example 10
[0270] In order to evaluate the toxicity evaluation effect of the recombinant luminescent bacteria of the present invention, the acute toxicity experiment of o-xylene to 502 luminescent bacteria was carried out with reference to the standard of "Determination of Acute Toxicity of Water Quality-Luminescent Bacteria Method (GB / T 15441-1995)".
[0271] The specific process includes: before the experiment, 502 luminescent bacteria were revived and subcultured for future use. The IC value of the o-xylene solution was determined by preliminary experiments. 50 After the concentration range is determined, different concentration gradients of o-xylene solution are set within this range, namely 0M, 2M, 4M, 6M, 8M and 10M, with 3 parallels for each gradient. All concentrations of solutions are gradiently diluted using sterilized 3 wt% NaCl solution. A white opaque 96-well microplate was used, and 99 μL of o-xylene solution and 1 μL of 502 luminescent bacteria solution were added to each well. The plate was quickly placed on a 25±2°C plate shaker for mixing for 15 minutes, and the relative light units were measured using the Thermo multi-function microplate reader chemiluminescence module. The relative luminescence inhibition rate I corresponding to the o-xylene solutions of different concentrations was calculated. With different concentrations of C as the horizontal axis and the relative luminescence inhibition rate I as the vertical axis, the dose-effect curve of the biological toxicity of the test substance was drawn (such as Fig.12 As shown), we selected Probit regression analysis in SPSS software and used Logit function for nonlinear fitting, and the obtained functional relationship was: y = -0.301x 2 -6.7679x+108,15,R 2 =0.9404.
[0272] Test Example 4
[0273] Calculation of IC of organic pollutants in Examples 8-10 and Comparative Examples 8-10 50 , the results are shown in Table 3.
[0274] Table 3
[0275] serial number Bacteria Organic matter <![CDATA[IC 50 (mM)]]> Example 8 Recombinant luminescent bacteria formaldehyde 0.662 Comparative Example 8 PP502 formaldehyde 10.143 Example 9 Recombinant luminescent bacteria phenol 4.988 Comparative Example 9 PP502 phenol 16.961 Example 10 Recombinant luminescent bacteria o-Xylene 0.41M Comparative Example 10 PP502 o-Xylene 0.52M
[0276] It can be seen from Table 3 that the recombinant luminescent bacteria of the present invention are more sensitive to formaldehyde, phenol and o-xylene than the luminescent bacteria PP502.
[0277] The preferred embodiments of the present invention are described in detail above, but the present invention is not limited thereto. Within the technical concept of the present invention, the technical solution of the present invention can be subjected to a variety of simple modifications, including the combination of various technical features in any other suitable manner, and these simple modifications and combinations should also be regarded as the contents disclosed by the present invention and belong to the protection scope of the present invention.
Claims
1. A method for detecting the biological toxicity of pollutants based on recombinant luminescent bacteria, characterized in that: The method comprises the following steps: (1) culturing the recombinant luminescent bacteria to obtain a recombinant luminescent bacteria liquid; (2) The pollutant solutions of different concentrations and the blank control group were mixed with the recombinant luminescent bacteria solution, and the relative luminescence units were measured respectively. The relative luminescence inhibition rate I corresponding to the pollutant solutions of different concentrations was calculated, the dose-effect curve was drawn, and the IC was calculated. 50 , the biotoxicity of pollutants is based on IC 50 To judge by the size; Wherein, the recombinant luminous bacteria is Escherichia coli DH5αpGE-NluxCDABE, and the pollutants are heavy metal compounds and / or organic matter.
2. The method according to claim 1, characterized in that: The relative luminescence inhibition rate I is calculated according to formula (1): I=RLU / RLU0×100% Formula (1) Among them, RLU is the relative luminescence unit corresponding to different pollutant solutions, and RLU0 is the relative luminescence unit corresponding to the blank control group, and the unit is %.
3. The method according to claim 1, characterized in that The recombinant luminescent bacteria is obtained by stably transforming Escherichia coli DH5α into a pGENluxCDABE plasmid carrying luxCDABE.
4. The method according to any one of claims 1 to 3, characterized in that: The heavy metal in the heavy metal compound is selected from one or more of gold, silver, copper, iron, mercury, lead, zinc and cadmium; Preferably, the heavy metal compound is a heavy metal inorganic salt and / or a heavy metal organic salt; More preferably, the heavy metal compound is selected from one or more of heavy metal sulfates, heavy metal nitrates and heavy metal hydrochlorides; Particularly preferably, the heavy metal compound is selected from one or more of zinc sulfate, cadmium chloride and copper sulfate.
5. The method according to any one of claims 1 to 4, characterized in that: The organic matter is selected from one or more of fatty ketones, fatty alcohols, nitriles, alkyl sulfoxides, fatty aldehydes and phenols; Preferably, the organic matter is selected from one or more of acetone, acetonitrile, ethanol, dimethyl sulfoxide, phenol, o-xylene and formaldehyde.
6. The method according to any one of claims 1 to 5, characterized in that: The step (1) comprises: inoculating the recombinant luminescent bacteria into a culture medium for culturing, then performing subculture, centrifuging, and resuspending to obtain a recombinant luminescent bacteria liquid.
7. The method according to claim 6, characterized in that The culture medium contains ampicillin, and the concentration of the ampicillin is 45-60 mg / L.
8. The method according to claim 6 or 7, characterized in that: The culture conditions include: temperature of 20-45°C, time of 14-20h, and rotation speed of 100-150rmp; Preferably, the conditions for the subculture include: a temperature of 20 to 45° C., a time of 20 to 60 hours, and a rotation speed of 100 to 150 rpm.
9. The method according to any one of claims 6 to 8, characterized in that: Subculture until the OD of the bacterial solution 600 When the value is 0.2-0.4, centrifugation is performed; Preferably, when the OD of the bacterial solution is 600 When the value is 0.2 to 0.4, the relative luminous unit is 0.8×10 7 ~1.2×10 7 .
10. The method according to any one of claims 6 to 9, characterized in that: The centrifugal conditions include: temperature of 1-8°C, time of 3-7 min, and rotation speed of 3000-8000 rpm.
11. The method according to any one of claims 6 to 10, characterized in that: Water or NaCl solution is used for re-suspending. Preferably, the concentration of the NaCl solution is 0.3-0.8 wt %.
12. The method according to any one of claims 1 to 11, characterized in that: The step (2) further includes: before mixing the pollutant solutions of different concentrations with the recombinant luminescent bacteria solution, conducting a preliminary experiment to determine the concentration range of the pollutants.
13. The method according to claim 12, characterized in that The preliminary experiment includes: diluting the pollutant in a gradient manner, with a gradient difference of 10 times, determining 5 to 8 concentrations of the pollutant solution, and then mixing the pollutant solutions of different concentrations and the blank control group with the recombinant luminescent bacteria solution, respectively, and determining the relative luminescence units, and calculating the relative luminescence inhibition rate I corresponding to the pollutant solutions of different concentrations to determine the IC 50 The pollutant concentration range is taken as the pollutant concentration range; Preferably, in the preliminary experiment, a NaCl solution with a concentration of 0.3 to 0.8 wt % is used as a blank control group; Preferably, in the preliminary experiment, a NaCl solution with a concentration of 0.3 to 0.8 wt% is used to gradiently dilute the pollutant; Preferably, the mixing time is 12 to 20 minutes.
14. The method according to any one of claims 1 to 13, characterized in that: In step (2), the blank control group is a NaCl solution with a concentration of 0.3 to 0.8 weight %.
15. The method according to any one of claims 1 to 14, characterized in that: Step (2) comprises: after a preliminary experiment, adding 98 to 100 μL of pollutant solutions of different concentrations and a blank control group and 1 μL of recombinant luminescent bacteria solution to a microplate, shaking, mixing, and respectively measuring relative luminescence units, and calculating relative luminescence inhibition rates I corresponding to pollutant solutions of different concentrations; Preferably, pollutant solutions of different concentrations are prepared using NaCl solutions with a concentration of 0.3 to 0.8 weight percent; Preferably, the mixing time is 12 to 20 minutes.
16. The method according to any one of claims 1 to 15, characterized in that: The abscissa of the dose-effect curve is the concentration C of pollutant solutions of different concentrations; the ordinate is the relative luminescence inhibition rate I.
Citation Information
Patent Citations
Biotoxicity detection method for industrial wastewater on the basis of genetic-recombined photogenic bacteria
CN108226493A
